IL-17基因多态性与中国汉族人群炎症性肠病的关系

表4 IL-17A/F基因多态性与CD临床表现之间的关系

	n	OR (95%CI)
		rs2275913		rs8193036		rs3804513		rs763780
		Allele A	AA+AG vs GG	Allele	TTT+CT vs CC	Allele	TAT+TT vs AA	Allele C	CT+CC vs TT
病变范围
回肠	21	0.82	0.69	2.19	3.01	0.96	0.94	1.96	2.27
		(0.34-1.97)	(0.19-2.50)	(0.91-5.27)	(0.76-11.82)	(0.27-3.39)	(0.24-3.76)	(0.53-7.19)	(0.55-9.32)
结肠	22	0.99	1.92	1.08	1.58	1.21	1.26	-	-
		(0.43-2.31)	(0.41-9.46)	(0.43-2.71)	(0.48-5.22)	(0.39-3.74)	(0.35-4.440	-	-
回结肠	37	1.18	2.24	0.99	0.92	0.87	0.84	3.60a	4.95b
		(0.61-1.29)	(0.62-8.09)	(0.47-2.09)	(0.59-2.37)	(0.32-2.35)	(0.29-2.48)	(1.51-8.60)	(1.81-13.54)
临床严重程度
轻度	24	0.84	2.48	1.49	1.97	1.49	0.95	1.24	1.35
		(0.31-1.99)	(0.51-12.06)	(0.60-3.72)	(0.55-7.05)	(0.60-3.72)	(0.24-3.76)	(0.27-5.69)	(0.27-6.71)
中度	50	1.09	1.74	1.23	1.22	1.15	1.19	2.02	2.35
		(0.59-1.99)	(0.64-4.74)	(0.62-2.37)	(0.52-2.87)	(0.50-2.65)	(0.47-2.99)	(0.81-5.06)	(0.87-6.39)

^aP = 0.02,

^bP = 0.003, vs CD组.